Caffeine doesn’t weaken arthritis drug’s effects

	Tweet

Caffeine does not appear to impair the effectiveness of methotrexate for treating rheumatoid arthritis (RA), Boston researchers report.

Methotrexate is the most commonly prescribed drug for slowing the progression of RA. It may exert some of its anti-inflammatory effects by boosting tissue levels of a protein called adenosine. Given that caffeine can block the cell receptors that adenosine acts on, it is possible that it could also blunt methotrexate’s effects.

Studies in rats have indeed found that high doses of caffeine weakened methotrexate’s actions, while some human studies have suggested it could have a similar effect in people.

To investigate, Dr. Elizabeth Benito-Garcia and colleagues from Brigham and Women’s Hospital and Harvard Medical School divided 264 patients with RA who were taking methotrexate into three roughly equal groups based on their caffeine consumption.

Their intake averaged about 212 milligrams daily, or just over 1.5 cups of coffee. People in the highest caffeine consumption group took in 422 mg of caffeine a day, or a bit more than the amount contained in three cups of coffee.

People in the moderate to high caffeine consumption groups did show higher disease activity scores and physician assessment scores, as well as more swollen joints, on average, but these differences were not statistically significant.

Caffeine intake in the study participants may not have been high enough to impact methotrexate’s effectiveness, Benito-Garcia and her colleagues note in an article in the Journal of Rheumatology. They think additional large studies looking at the impact of caffeine on methotrexate would be worthwhile.

SOURCE: Journal of Rheumatology, July 2006.

RELATED STORIES:
Osteoarthritis improves with self-management program   Gout prevalence swells in US over last 2 decades   Childhood Arthritis Raises Risk of Broken Bones   Arthritis pain may change with the weather   Heavy exercise may worsen arthritis damage   Bristol-Myers to issue arthritis drug data   15 Years After ACL Knee Reconstruction, 84% of Male Patients Still Highly Active   Being thin has downside for people with arthritis   Novel autoantibodies identified in patients with necrotizing myopathy   Magnets seen helpful for osteoarthritis   Obesity not apt to affect outcome of knee surgery   Enbrel especially helpful for early arthritis

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]